Adakveo

Novartis sickle cell drug’s approval formally revoked by EU regulators
BioPharma Dive
Sun, 08/6/23 - 09:27 pm
Novartis
Adakveo
sickle cell disease
Europe
EMA
Novartis' approved sickle cell disease drug fails to beat placebo in PhIII
Endpoints
Sun, 01/29/23 - 01:23 pm
Novartis
sickle cell disease
Adakveo
clinical trials
Novartis, GBT sickle cell drugs face coverage hurdles as gene therapy threats loom: survey
Fierce Pharma
Wed, 06/30/21 - 12:09 am
Novartis
Adakveo
Global Blood Therapeutics
Oxbryta
sickle cell disease
gene therapy
New sickle cell drugs priced too high, ICER says
BioPharma Dive
Fri, 03/13/20 - 12:43 pm
sickle cell disease
drug pricing
ICER
Novartis
Global Blood Therapeutics
RWE
Adakveo
Oxbryta
Sickle Cell Disease: After Years Of Neglect Some Promise For Sufferers
Forbes
Mon, 02/17/20 - 10:26 am
sickle cell disease
Oxbryta
Adakveo
Endari
olinciguat
CRISPR
Trifecta of sickle cell disease therapies extend life expectancy, but are not cost-effective — ICER
Endpoints
Fri, 01/24/20 - 10:30 am
ICER
sickle cell disease
Novartis
Adakveo
Global Blood Therapeutics
Oxbryta
Emmaus Life Sciences
Endari
3 Rare Disease Drug Launches to Watch in 2020
Motley Fool
Sat, 01/4/20 - 07:38 pm
Global Blood Therapeutics
sickle cell disease
Oxbryta
Novartis
SCD
Adakveo
Alnylam
Givlaari
acute hepatic porphyria
FDA
FDA Approves 5 New Costly Drugs Well Ahead of PDUFA Dates
RAPS.org
Wed, 11/27/19 - 12:39 pm
FDA
Vertex Pharmaceuticals
Trikafta
Novartis
Adakveo
Alnylam
Givlaari
BeiGene
Brukinsa
Global Blood Therapeutics
Oxbryta
drug approvals
Global Blood Therapeutics Goes Head to Head With Novartis On Sickle Cell
Motley Fool
Sun, 11/24/19 - 11:26 pm
Global Blood Therapeutics
voxelotor
Novartis
Adakveo
sickle cell disease
FDA Approves Crizanlizumab: Here Is A New Drug For Sickle Cell Disease
Forbes
Sun, 11/17/19 - 08:42 pm
Novartis
Adakveo
FDA
crizanlizumab
sickle cell disease
Novartis sickle-cell drug wins FDA approval
Biopharma Dive
Fri, 11/15/19 - 11:57 pm
FDA
Novartis
Adakveo
sickle cell disease